par  Aeby, Alec  ;Wermenbol, Vanessa
;Wermenbol, Vanessa  ;Ciardelli, Roberta;Mller, M.F.;Wetzburger, Catherine
;Ciardelli, Roberta;Mller, M.F.;Wetzburger, Catherine  ;Van Bogaert, Patrick
;Van Bogaert, Patrick 
Référence Revue médicale de Bruxelles, 36, 4, page (219-222)
Publication Publié, 2015-09
           ;Wermenbol, Vanessa
;Wermenbol, Vanessa  ;Ciardelli, Roberta;Mller, M.F.;Wetzburger, Catherine
;Ciardelli, Roberta;Mller, M.F.;Wetzburger, Catherine  ;Van Bogaert, Patrick
;Van Bogaert, Patrick 
Référence Revue médicale de Bruxelles, 36, 4, page (219-222)
Publication Publié, 2015-09
                                                                                                       
			Article révisé par les pairs
                                                  
        | Résumé : | Advances in pediatric medicine have enabled a decrease in perinatal mortality, especially among infants born preterm (< 32 weeks gestational age) or low birth weight (< 1.500 g). However, this population is exposed to a greater risk of neurological sequelae. This is why the creation of specific follow-up program are mandatory to screen at-risk children to offer them a support able to minimize the impact of prematurity on their future neurological development. | 



